Fax: +82-2-3410-0025
1934-6638/asset/olbannerleft.jpg?v=1&s=248507ce5877945e3da8cea0c5210f53552322db)
1934-6638/asset/olbannerright.jpg?v=1&s=ac82d44877e329c9cc7c1dc2ce7184d3082a8921)
Original Article
You have free access to this content
Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule
Article first published online: 12 JUL 2011
DOI: 10.1002/cncy.20179
Copyright © 2011 American Cancer Society
Additional Information
How to Cite
Kang, G., Cho, E. Y., Shin, J. H., Chung, J.-H., Kim, J. W. and Oh, Y. L. (2012), Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule. Cancer Cytopathology, 120: 44–51. doi: 10.1002/cncy.20179
- †
Fax: +82-2-3410-0025
Publication History
- Issue published online: 13 FEB 2012
- Article first published online: 12 JUL 2011
- Manuscript Accepted: 8 JUN 2011
- Manuscript Revised: 7 JUN 2011
- Manuscript Received: 7 MAR 2011
REFERENCES
- 1, . Quest for a uniform cyto-diagnostic approach to thyroid aspirates: a consensus proposal. Diagn Cytopathol. 2006; 34: 85-86.
- 2, , , et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008; 36: 425-437.
- 3, , , , . Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery. 1989; 106: 980-985; discussion 985-986.
- 4, , , . Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007; 111: 306-315.
- 5, , , et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007; 111: 508-516.
- 6, , , . Nondiagnostic thyroid fine-needle aspiration cytology: management dilemmas. Thyroid. 2001; 11: 1147-1151.
- 7, , , et al. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2004; 89: 5175-5180.
- 8, , , et al. Thyroid cancer: 1999 update. Ann Surg Oncol. 2000; 7: 376-398.
- 9, , , , , . High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 2003; 63: 1454-1457.
- 10, , , et al. Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. Am J Surg Pathol. 2006; 30: 216-222.
- 11, , , et al. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab. 2003; 88: 2318-2326.
- 12, , , et al. Mutations of the BRAF gene in human cancer. Nature. 2002; 417: 949-954.
- 13, , , et al. BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab. 2005; 90: 6373-6379.
- 14. BRAF mutation in thyroid cancer. Endocr Relat Cancer. 2005; 12: 245-262.
- 15, , , , . Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J. 2004; 45: 818-821.
- 16, , , et al. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol (Oxf). 2006; 65: 660-666.
- 17, , , et al. Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. Radiology. 2008; 247: 762-770.
- 18, , , et al. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population. J Clin Endocrinol Metab. 2010; 95: 3693-3700.
- 19, , , et al. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status. J Clin Endocrinol Metab. 2011; 96: 658-664.
- 20, . The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol. 2009; 117: 195-202.
- 21, , . Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med. 1993; 13: 699-709.
- 22. Reporting thyroid fine-needle aspiration: literature review and a proposal. Diagn Cytopathol. 2006; 34: 67-76.
- 23, , , et al. Contribution of molecular testing to thyroid fine-needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance”. Cancer Cytopathol. 2010; 118: 17-23.
- 24, , , et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009; 94: 2092-2098.
- 25, , , et al. Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study. Thyroid. 2011 [Epub ahead of print].
- 26, , , , . Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. J Clin Endocrinol Metab. 2006; 91: 3603-3610.
- 27, , . Targeting BRAF in thyroid cancer. Br J Cancer. 2007; 96: 16-20.
- 28. BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev. 2007; 28: 742-762.
- 29, , , et al. BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab. 2008; 93: 3943-3949.
- 30, , , et al. BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer. J Clin Oncol. 2009; 27: 2977-2982.
- 31, , . The utility of BRAF testing in the management of papillary thyroid cancer. Oncologist. 2010; 15: 1285-1293.